Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Porcine beta-defensin 2 displays broad antimicrobial activity against pathogenic intestinal bacteria.

Veldhuizen EJ, Rijnders M, Claassen EA, van Dijk A, Haagsman HP.

Mol Immunol. 2008 Jan;45(2):386-94. Epub 2007 Jul 20.

PMID:
17658606
2.

Diversity and regulation in the NF-kappaB system.

Wietek C, O'Neill LA.

Trends Biochem Sci. 2007 Jul;32(7):311-9. Epub 2007 Jun 11.

PMID:
17561400
3.

Human alpha- and beta-defensins block multiple steps in herpes simplex virus infection.

Hazrati E, Galen B, Lu W, Wang W, Ouyang Y, Keller MJ, Lehrer RI, Herold BC.

J Immunol. 2006 Dec 15;177(12):8658-66.

4.

Inhibition of vesicular stomatitis virus infection in epithelial cells by alpha interferon-induced soluble secreted proteins.

Basu M, Maitra RK, Xiang Y, Meng X, Banerjee AK, Bose S.

J Gen Virol. 2006 Sep;87(Pt 9):2653-62.

PMID:
16894205
5.

Cutting edge: human beta defensin 3--a novel antagonist of the HIV-1 coreceptor CXCR4.

Feng Z, Dubyak GR, Lederman MM, Weinberg A.

J Immunol. 2006 Jul 15;177(2):782-6.

7.

Lipid-specific membrane activity of human beta-defensin-3.

Böhling A, Hagge SO, Roes S, Podschun R, Sahly H, Harder J, Schröder JM, Grötzinger J, Seydel U, Gutsmann T.

Biochemistry. 2006 May 2;45(17):5663-70.

PMID:
16634647
8.

Human beta-defensins suppress human immunodeficiency virus infection: potential role in mucosal protection.

Sun L, Finnegan CM, Kish-Catalone T, Blumenthal R, Garzino-Demo P, La Terra Maggiore GM, Berrone S, Kleinman C, Wu Z, Abdelwahab S, Lu W, Garzino-Demo A.

J Virol. 2005 Nov;79(22):14318-29.

9.

Comparative effects of two neutralizing anti-respiratory syncytial virus (RSV) monoclonal antibodies in the RSV murine model: time versus potency.

Mejías A, Chávez-Bueno S, Ríos AM, Aten MF, Raynor B, Peromingo E, Soni P, Olsen KD, Kiener PA, Gómez AM, Jafri HS, Ramilo O.

Antimicrob Agents Chemother. 2005 Nov;49(11):4700-7.

10.

Human {beta}-defensin 2 is expressed and associated with Mycobacterium tuberculosis during infection of human alveolar epithelial cells.

Rivas-Santiago B, Schwander SK, Sarabia C, Diamond G, Klein-Patel ME, Hernandez-Pando R, Ellner JJ, Sada E.

Infect Immun. 2005 Aug;73(8):4505-11.

12.

Transcriptional regulation of beta-defensin-2 by lipopolysaccharide in cultured human cervical carcinoma (HeLa) cells.

Mineshiba J, Myokai F, Mineshiba F, Matsuura K, Nishimura F, Takashiba S.

FEMS Immunol Med Microbiol. 2005 Jul 1;45(1):37-44. Epub 2005 Feb 10.

13.

Respiratory syncytial virus-induced acute and chronic airway disease is independent of genetic background: an experimental murine model.

Chávez-Bueno S, Mejías A, Gómez AM, Olsen KD, Ríos AM, Fonseca-Aten M, Ramilo O, Jafri HS.

Virol J. 2005 May 25;2:46.

14.

Respiratory syncytial virus infection in elderly and high-risk adults.

Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE.

N Engl J Med. 2005 Apr 28;352(17):1749-59.

16.
17.

Inhibition of respiratory viruses by nasally administered siRNA.

Bitko V, Musiyenko A, Shulyayeva O, Barik S.

Nat Med. 2005 Jan;11(1):50-5. Epub 2004 Dec 26.

PMID:
15619632
18.

Increased bronchoalveolar lavage human beta-defensin type 2 in bronchiolitis obliterans syndrome after lung transplantation.

Ross DJ, Cole AM, Yoshioka D, Park AK, Belperio JA, Laks H, Strieter RM, Lynch JP 3rd, Kubak B, Ardehali A, Ganz T.

Transplantation. 2004 Oct 27;78(8):1222-4.

PMID:
15502724
19.

Beta-defensins and LL-37 in bronchoalveolar lavage fluid of patients with cystic fibrosis.

Chen CI, Schaller-Bals S, Paul KP, Wahn U, Bals R.

J Cyst Fibros. 2004 Mar;3(1):45-50.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk